Medication info
Gliphosin M Tablet 2/500 mg

Gliphosin M Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
White oblong film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201106982 · Approved 2011.09.23 · Insurance code 642104110

Summary

Main use
Improves glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improves glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes by combining glimepiride and metformin while supporting dietary and exercise therapy.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, and it may be dangerous, especially if kidney function is rapidly declining. If dehydration, severe diarrhea, vomiting, or fever occurs, the medication should be temporarily discontinued, and consultation with a doctor is necessary. Patients with impaired kidney function or taking drugs that may affect kidney function should exercise special caution when using this medication. This drug may increase the risk of cardiovascular mortality, so both patients and caregivers should thoroughly understand its risks and benefits. Insulin-dependent diabetes patients, acute metabolic acidosis patients, patients with severe liver disease, pregnant or breastfeeding women, and patients with severe kidney impairment should not use this medication. Especially, the administration of this medication should be suspended before and after procedures using iodine contrast agents, and it should not be re-administered until kidney function stabilizes. Patients at high risk of hypoglycemia, those in a state of malnutrition, elderly individuals, and patients with liver failure should use this medication cautiously while closely monitoring blood sugar levels during the initial dosing period. Gastrointestinal disturbances (such as diarrhea, nausea, vomiting) may occur during the use of this medication, most of which are temporary, but if severe, medical consultation is recommended. Allergic reactions or hematological abnormalities may arise, so any unusual symptoms should be promptly reported to a doctor. This medication may decrease vitamin B12 levels, so it is necessary to regularly check vitamin B12 status during long-term use. During diabetes treatment, blood glucose and glycosylated hemoglobin levels should be regularly tested to monitor therapeutic effects, and medication dosage adjustments may be necessary with lifestyle changes or the occurrence of other diseases. Excessive alcohol consumption should be avoided during treatment with this medication, and precautions should be taken when driving or operating machinery due to potential decreased alertness from hypoglycemia or hyperglycemia. During pregnancy or breastfeeding, insulin therapy is recommended instead of this medication, and special attention is needed for children and the elderly. Overdose may result in hypoglycemia or lactic acidosis; immediate medical attention should be sought for proper treatment. This medication may interact with several other drugs, so it is important to inform the physician or pharmacist if taking other medications. This medication should be kept out of reach of children and should not be transferred to another container.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, indigestion, constipation, abdominal pain, metallic taste, visual impairment, taste disorder, erythema, itching, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, anemia, neutropenia, agranulocytosis, pancytopenia, peripheral neuropathy, vitamin B12 deficiency, increased hepatic enzymes, liver dysfunction, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, headache, extreme hunger, fatigue, sleepiness, malaise, drowsiness, sleep disorders, instability, aggression, attention deficit, inability to concentrate, abnormal reactions, depression, confusion, speech disorder, aphasia, tremors, paralysis, sensory disturbances, dizziness, inability to self-regulate, delirium, cerebral seizures, loss of consciousness, coma, weakened respiration, slow heartbeat, sweating, moist skin, anxiety, rapid heartbeat, hypertension, palpitations, angina, deep vein thrombosis, dizziness, abnormal liver function, prostate enlargement, palpitations, dizziness, leg edema, cardiac arrest, rectal carcinoma, arthralgia, indigestion, facial edema, erectile dysfunction, flushing, gastritis, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, preferably at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.